MBRX · Moleculin Biotech, Inc. · Documents
$6.50
+0.61 (+10.36%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, the Company had an accumulated deficit of $226.5 million since inception and had not yet generated any revenues from operations. Additionally, management anticipates that its cash on hand of $7.3 million as of June 30, 2026, is not sufficient to fund its planned operations for a period of at least one year from when these condensed consolidated financial statements are issued. These factors raise substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$5.74M
Shares
973,869
Volume · Oct 23
27.74K
Avg daily vol (4 sessions)
65.18K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2025-06-04 | — | |
| S-1 | — | 2025-06-02 | — | |
| 8-K | — | 2025-05-23 | — | |
| PRE 14A | — | 2025-05-23 | — | |
| 8-K | — | 2025-05-14 | — | |
| 10-Q | — | 2025-05-13 | 2025-03-31 | |
| 8-K | — | 2025-05-12 | — | |
| 8-K | — | 2025-05-09 | — | |
| 8-K | — | 2025-05-07 | — | |
| 8-K | — | 2025-05-06 | — | |
| 8-K | — | 2025-05-05 | — | |
| 10-K/A | — | 2025-04-30 | 2024-12-31 | |
| 8-K | — | 2025-04-29 | — | |
| 8-K | — | 2025-04-25 | — | |
| 8-K | — | 2025-04-21 | — | |
| 10-K/A | — | 2025-04-18 | 2024-12-31 | |
| 8-K | — | 2025-04-17 | — | |
| 8-K | — | 2025-04-09 | — | |
| 8-K | — | 2025-04-01 | — | |
| S-1 | — | 2025-03-31 | — | |
| 8-K | — | 2025-03-24 | — | |
| 8-K | — | 2025-03-24 | — | |
| 10-K | — | 2025-03-21 | 2024-12-31 | |
| DEF 14A | — | 2025-03-13 | 2025-04-09 | |
| 8-K | — | 2025-03-06 | — | |
| PRE 14A | — | 2025-03-03 | 2025-04-09 | |
| 8-K | — | 2025-02-26 | 2025-02-25 | |
| 8-K | — | 2025-02-13 | — | |
| 8-K | — | 2025-02-13 | — | |
| S-1/A | — | 2025-02-11 | — | |
| 8-K | — | 2025-02-11 | — | |
| 8-K | — | 2025-02-10 | 2025-02-09 | |
| S-1/A | — | 2025-02-10 | — | |
| S-1/A | — | 2025-01-29 | — | |
| 8-K | — | 2025-01-27 | — | |
| 8-K | — | 2025-01-27 | — | |
| 8-K/A | — | 2025-01-27 | — | |
| 8-K | — | 2025-01-08 | — | |
| 8-K | — | 2025-01-08 | — | |
| 8-K | — | 2024-12-18 | — | |
| S-1 | — | 2024-12-13 | — | |
| 8-K | — | 2024-12-11 | — | |
| 8-K | — | 2024-11-18 | — | |
| 8-K | — | 2024-11-18 | — | |
| 8-K | — | 2024-11-14 | — | |
| 8-K | — | 2024-11-14 | — | |
| 8-K | — | 2024-11-12 | — | |
| 8-K | — | 2024-11-12 | 2024-11-11 | |
| 8-K | — | 2024-11-12 | — | |
| 10-Q | — | 2024-11-08 | 2024-09-30 |
Showing 101–150 of 407 filings